Alexion Pharmaceuticals v Amgen (UPC_Coa-405/2024) and Alexion Pharmaceuticals v Samsung Bioepis NL BV (UPC_CoA-402/2024); December 20, 2024.

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...

His extensive industry background includes well-known companies such as ATK/Vista Outdoors, Magnum Research, Bushnell, Michaels of Oregon, and Birchwood Laboratories. He is known for his commitment to ...

His tenure at Amgen included roles in sales and marketing ... “Brian is an accomplished industry professional with a strong background in hematology and oncology, and he is ideally suited ...

JPM25 is in full swing as several pharma powerhouses—including Merck, Lilly and Amgen—detail their strategies for growth in the coming year. After an explosive opening marked by a suite of ...

RALEIGH, N.C. (January 13, 2025) – The first group of apprentices has officially signed on with Amgen in a unique program that will prepare a skilled workforce for the biopharmaceutical leader's ...

Amgen is one of those would-be competitors and ... you would want a partner that has some experience in these large metabolic indications, you know, like a lipid background, or experience with ...

The latest trading session saw Amgen (AMGN) ending at $267.10, denoting a -1.14% adjustment from its last day's close. The stock fell short of the S&P 500, which registered a gain of 0.12% for the ...

Amgen is best known for its success in the biosimilar market. Image credit: Shutterstock / Michael Vi. Amgen has reported that its once-monthly dosing regimen and manufacturing capabilities will be ...